Previous 10 | Next 10 |
Repligen (NASDAQ: RGEN ): Q1 Non-GAAP EPS of $0.32; GAAP EPS of $0.18 beats by $0.07 . More news on: Repligen Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
Reports record quarterly revenue of $76.1 million Overall revenue grew 25% year-over-year, with organic growth of 16% Strong order load through first four months WALTHAM, Mass., May 06, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focu...
When Repligen (NASDAQ: RGEN) reports first-quarter 2020 earnings this week, investors will be expecting a downturn from the coronavirus pandemic. That's because the bioprocess engineering leader generated 65% of full-year 2019 revenue from customers engaged in clinical trials. Many pharmaceu...
WALTHAM, Mass., April 22, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2020 financial results on Wednesday, May 6, 2020. The Company will issue a press release before the market opens and will host a conference ca...
Shares of Repligen (NASDAQ: RGEN) rose nearly 13% last month, according to data provided by S&P Global Market Intelligence . That easily bested the 12.5% drop of the S&P 500 in March. But the stock's performance probably had little to do with the coronavirus pandemic. Investors l...
After tumbling by double digits in March, major stock markets have rallied in early April on seemingly any and every indication that the coronavirus pandemic might be plateauing. That cautious optimism might be wishful thinking on the part of Wall Street, however: It's possible second waves...
It's the darkest right before the dawn... Italy’s grim arc of death begins to follow other countries that have come out on the other side. NYC is about to follow this difficult transition from a spike of death to a lesser toll in the coming weeks. We also are very close to getting...
This article is essentially a continuation of yesterday’s note I want to take a tactical approach to reallocate the cash we worked so hard to generate. In fact, you should still be trimming into this rally today and tomorrow. I maintain that this rally and possibly running tomor...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
In this episode of Rule Breaker Investing , Motley Fool co-founder David Gardner shares with you his investment philosophy and how you can use it to beat the market. There are 10 and a half chapters that take you through everything from how to invest in a downturn to how today's science ...
News, Short Squeeze, Breakout and More Instantly...
WALTHAM, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2024 financial results on Tuesday, July 30, 2024. The Company will issue a press release before the market opens and will host a conference call at ...
2024-07-04 04:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-21 14:00:08 ET Daniel Arias from Stifel Nicolaus issued a price target of $207.00 for RGEN on 2024-06-21 12:12:00. The adjusted price target was set to $207.00. At the time of the announcement, RGEN was trading at $123.16. The overall price target consensus is at...